Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 10041-10050 of 12128

Page
per page
  1. CYM 5541
    B5755 CYM 5541
    Summary: sphingosine-1-phosphate receptor 3 (S1P3) allosteric agonist
      Soluble in DMSO
  2. JW 642
    B5759 JW 642
    Summary: monoacylglycerol lipase (MAGL) inhibitor
      Soluble in DMSO
  3. Endomorphin-1
    A1013 Endomorphin-1
    Summary: Agonist of μopioid receptors,highly potent and selective
      ≥14.9 mg/mL
  4. GNE-9605
    B4761 GNE-9605
    Summary: LRRK2 inhibitor, brain-penetrant, potent and selective
      ≥22.5 mg/mL
  5. TCS 3035
    B7783 TCS 3035
    Summary: GPR35 agonist
      <27.93 mg/mL
  6. Remodelin hydrobromide
    B4887 Remodelin hydrobromide
    Target: NAT10
    Summary: NAT10 inhibitor
      ≥36.3 mg/mL
  7. K-115
    B4809 K-115
    Summary: Selective Rho kinase inhibitor
      insoluble in EtOH; ≥123.2 mg/mL
  8. ML 349
    B4934 ML 349
    Summary: lysophospholipase 2 (LYPLA2) inhibitor
      Soluble in DMSO
  9. Methylprednisolone Sodium Succinate
    B4953 Methylprednisolone Sodium Succinate
    Target: Glucocorticoid Receptors
    Summary: glucocorticoid
      ≥49.7 mg/mL
  10. (R)-Crizotinib
    A3020 (R)-Crizotinib
     3 Citation
    Target: c-MET
    Summary: C-MET/ALK inhibitor,potent and ATP-competitve
      insoluble in H2O; insoluble in EtOH; ≥7.51 mg/mL

Items 10041-10050 of 12128

Page
per page